Following the conclusion of the annual general meeting, Dr. Cheng Yanjie has retired by rotation as a non-executive director of SINOPHARM TECH (08156). Mr. Diao Zhiqiang and Mr. Yu Bingming were elected as independent non-executive directors by shareholders during the meeting.

The board further announced that Mr. Xu Dong'an has resigned as an independent non-executive director due to other business commitments, effective from December 19, 2025 (after the AGM).

Additionally, the board disclosed the following committee composition changes, all effective from December 19, 2025: 1. Mr. Xu has stepped down as chairman of the nomination committee and as a member of the audit, remuneration, and nomination committees. 2. Ms. Guo Shuyi has been appointed as a member of the remuneration and nomination committees. 3. Mr. Liu Fei has been appointed as a member and chairman of the nomination committee. 4. Mr. Diao has joined the audit, remuneration, and nomination committees. 5. Mr. Yu has been appointed to the audit, remuneration, and nomination committees.